Safety and interim results from a phase II, single-arm study of atezolizumab and bevacizumab in Merkel cell carcinoma (MCC).

被引：1
|
作者：
Ferrarotto, Renata
Mata, Javier
Mott, Frank
Bhosale, Priya
Rubin, M. Laura
Altan, Mehmet
Dervin, Shannon
Yun, Cindy
Yao, James C.
Halperin, Daniel M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Div Canc Med, Houston, TX 77030 USA
[3] Genentech Inc, San Francisco, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e21006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21006
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major
    Yesilipek, M. Akif
    Karasu, Gulsun
    Kaya, Zuhre
    Kuskonmaz, Baris B.
    Uygun, Vedat
    Dag, Ilkiz
    Birkent, Asli
    Ertem, Mehmet
    BLOOD, 2015, 126 (23)
  • [42] A single-arm feasibility phase II study of EMF (erlotinib
    Baa, Annie Kanchan
    Sharma, Atul
    Bhaskar, Suman
    Biswas, Ahitagni
    JeeBharti, Sacchidanand
    Thakar, Alok
    Kumar, Rajeev
    Pramanik, Raja
    ECANCERMEDICALSCIENCE, 2022, 16
  • [43] Treatment of Advanced or Metastatic Hepatocellular Cancer (HCC) Preliminary Safety Analysis of a Single-ARM Phase II Study of Bevacizumab and Rad001
    Treiber, Gerhard
    GASTROENTEROLOGY, 2010, 138 (05) : S811 - S811
  • [44] Treatment of advanced or metastatic hepatocellular cancer (HCC) - preliminary safety analysis of a single-arm phase II study of bevacizumab and RAD001
    Treiber, G.
    ONKOLOGIE, 2010, 33 : 8 - 9
  • [45] Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension in a single-arm Phase II study
    Straume, Oddbjorn
    Schuster, Cornelia
    Puntervoll, Hanne
    Eikesdal, Hans P.
    Heinrich, Daniel
    Geisler, Stephanie B.
    Geisler, Jurgen
    Molven, Anders
    Lonning, Per E.
    Akslen, Lars
    CANCER RESEARCH, 2012, 72
  • [46] Results of a phase II study of atezolizumab and bevacizumab in non-clear cell renal cell carcinoma (nccRCC) and clear cell renal cell carcinoma with sarcomatoid differentiation (sccRCC).
    Mckay, Rana R.
    McGregor, Bradley Alexander
    Gray, Kathryn
    Steinharter, John A.
    Walsh, Meghara K.
    Braun, David A.
    Flaifel, Abdallah
    VanAllen, Eliezer
    Wei, Xiao X.
    Signoretti, Sabina
    Harshman, Lauren Christine
    Vaishampayan, Ulka N.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [47] Final Results from SAUL, a Single-arm International Study of Atezolizumab in Unselected Patients with Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
    Sternberg, Cora N.
    Loriot, Yohann
    Choy, Ernest
    Castellano, Daniel
    Lopez-Rios, Fernando
    Banna, Giuseppe Luigi
    Zengerling, Friedemann
    De Giorgi, Ugo
    Gedye, Craig
    Masini, Cristina
    Bamias, Aristotelis
    del Muro, Xavier Garcia
    Duran, Ignacio
    Powles, Thomas
    Retz, Margitta
    Gamulin, Marija
    Geczi, Lajos
    Huddart, Robert A.
    Calabro, Fabio
    Kandula, Geetha
    Skamnioti, Pari
    Merseburger, Axel S.
    EUROPEAN UROLOGY FOCUS, 2024, 10 (06): : 938 - 946
  • [48] Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
    Jiang, Yi
    Su, Ke
    Li, Han
    Wang, Chenjie
    Wu, Zhenying
    Chen, Jiali
    Zhang, Zhiyao
    He, Kun
    Han, Yunwei
    INVESTIGATIONAL NEW DRUGS, 2025, 43 (01) : 18 - 29
  • [49] Efficacy and safety of a combination of sintilimab, bevacizumab plus gemcitabine, and albumin-bound paclitaxel for initially unresectable gallbladder carcinoma: A prospective, single-arm phase II study.
    Wang, Miao
    Zhou, Jiamin
    Xu, Weiqi
    Pan, Qi
    Mao, Anrong
    Zhang, Ning
    Feng, Yun
    He, Xigan
    Lin, Zhenhai
    Wang, Longrong
    Zhang, Yongfa
    Zhu, Hongxu
    Ding, Zhiwe
    Wang, Yixiu
    Yu, Bingran
    Zhang, Ti
    Wang, Lu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 489 - 489
  • [50] Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients
    Tomita, Yoshihiko
    Tatsugami, Katsunori
    Nakaigawa, Noboru
    Osawa, Takahiro
    Oya, Mototsugu
    Kanayama, Hiroomi
    Kondoh, Chihiro Nakayama
    Sassa, Naoto
    Nishimura, Kazuo
    Nozawa, Masahiro
    Masumori, Naoya
    Miyoshi, Yasuhide
    Kuroda, Shingo
    Tanaka, Shingo
    Kimura, Akiko
    Tamada, Satoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (11) : 952 - 959
12345